Scinai Immunotherapeutics【SCNI】株式ニュース

名称	銘柄コード	市場	種別
Scinai Immunotherapeutics Ltd	SCNI	NASDAQ	Depository Receipt

	前日比	前日比 %	現在値	時刻
	-0.46	-13.69%	2.90	09:00:00

始値	安値	高値	終値	前日終値
3.30	2.72	3.40	3.09	3.36

この銘柄の詳細情報 »

最新ニュース

日付	時間	ソース	タイトル
2024/6/14	20:26	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/6/13	23:19	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/6/13	23:16	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/6/13	20:00	PRNUS	Scinai Immunotherapeutics Announces Receipt of a Letter of..
2024/6/07	20:00	PRNUS	Scinai Immunotherapeutics Regains Compliance with Nasdaq..
2024/5/29	03:14	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/5/25	05:01	PRNUS	Scinai Immunotherapeutics Announces Receipt of a Nasdaq..
2024/5/17	02:49	EDGAR2	Form 424B3 - Prospectus [Rule 424(b)(3)]
2024/5/16	06:10	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/5/16	05:01	PRNUS	Scinai Publishes FY 2023 Financial Statements, Files Annual..
2024/5/07	23:24	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/5/06	22:21	PRNUS	Scinai Immunotherapeutics Announces Receipt of Nasdaq..
2024/4/10	20:00	PRNUS	Scinai to showcase its novel biological local therapeutic..
2024/4/09	06:15	APS	Biotech Rips Following Five-Year Master Service Agreement..
2024/4/08	20:00	PRNUS	Scinai Immunotherapeutics' CDMO Unit Selected by Ayana..
2024/3/12	21:00	PRNUS	Scinai leadership to attend BIO-Europe Spring 2024
2024/2/29	22:45	PRNUS	Scinai to showcase its cGMP biologics CDMO and innovative..
2024/2/13	21:00	PRNUS	Scinai Welcomes Liat Halpert as Head of Business Development..
2024/1/31	06:19	EDGAR2	Form F-3 - Registration statement by foreign private issuers
2024/1/26	00:26	PRNUS	Scinai Immunotherapeutics Congratulates its Co-Lead..
2024/1/25	04:33	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
2024/1/19	01:50	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/1/12	21:32	EDGAR2	Form D - Notice of Exempt Offering of Securities
2024/1/09	22:45	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/1/05	06:37	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/1/05	06:01	PRNUS	Scinai Immunotherapeutics Announces Closing of Exercise of..
2024/1/04	20:15	PRNUS	Scinai Immunotherapeutics CEO Issues Letter to Shareholders
2024/1/02	23:58	EDGAR2	Form 424B3 - Prospectus [Rule 424(b)(3)]
2024/1/02	23:57	EDGAR2	Form 424B3 - Prospectus [Rule 424(b)(3)]
2024/1/02	23:26	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/1/02	23:24	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/1/02	22:24	EDGAR2	Form 424B3 - Prospectus [Rule 424(b)(3)]
2023/12/29	23:21	PRNUS	Scinai Immunotherapeutics Announces Exercise of Outstanding..
2023/12/27	21:15	PRNUS	Scinai (NASDAQ: SCNI) to Host Analyst and Investor Webinar..
2023/12/22	23:11	EDGAR2	Form F-1/A - Registration statement for certain foreign..
2023/12/14	20:21	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/12/12	21:26	PRNUS	Scinai Announces Promising Results in a Psoriatic Human Skin..
2023/12/11	22:11	PRNUS	Study published in Antiviral Research supports promise of..
2023/11/29	23:25	PRNUS	European Investment Bank (EIB) extends maturity of its..
2023/11/21	00:49	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/11/20	21:30	PRNUS	Scinai Immunotherapeutics Regains Compliance with Nasdaq's..
2023/11/13	22:25	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/11/07	20:09	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/11/06	21:30	GLOBE	Scinai Immunotherapeutics Announces Award of Non-Dilutive..
2023/11/04	05:30	GLOBE	Scinai Immunotherapeutics Provides Update Regarding Nasdaq..
2023/11/03	21:49	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/11/03	02:21	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/10/31	22:00	GLOBE	European Investment Bank (EIB) considering extending..
2023/10/31	21:23	GLOBE	Scinai Reports Third Quarter 2023 Financial Results and..
2023/10/31	05:59	EDGAR2	Form F-1 - Registration statement for certain foreign..